MR-409 promotes neurogenesis and improves neurological function after cerebral ischemia through attenuation of microglial activation.
Neurological recovery during the chronic phase of ischemic stroke (IS) remains a major clinical challenge. Our previous studies showed that the growth hormone-releasing hormone analogue (GHRH-A) MR-409 promotes neurogenesis and improves neurological outcomes. However, the underlying mechanisms remain unclear. Here, a t...